NemaMetrix
Eugene, US · Founded 2011 · Oregon corporation · 2 known investors
Founders & leadership
NemaMetrix was founded in 2011 by Janis Weeks and Shawn Lockery.
JW
Janis WeeksCo-founder
SL
Shawn LockeryCo-founder
MB
Matt BeaudetNamed on SEC filing
Investors · 2
Reported raises · per SEC filings
Form D private placements$9.4M disclosed across 5 of 6 rounds · 2015–2019
▶$5.2MraisedFeb 2019 · 8 investors · BiotechnologyRule 506(b)
▶$5.2MraisedFeb 2019 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- EVANGELINE GONZALEZDirector
- SHAWN LOCKERYExecutive Officer, Director
- MATT BEAUDETExecutive Officer, Director
- RICK MILLERDirector
- ANN BUNNENBERGDirector
- CHRIS CARLSONDirector
- KEVIN PADRICKDirector
- Offering amount
- $6.5M
- Amount sold
- $5.2M
- First sale
- Feb 2019
- Incorporated
- Corporation, Oregon
- Federal exemptions
- 06b
▶$1.6MraisedApr 2018 · 2 investors · BiotechnologyRule 506(b)
▶$1.6MraisedApr 2018 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Trisha BrockDirector
- Matt BeaudetExecutive Officer, Director
- Janis WeeksExecutive Officer, Director
- Amy TykesonDirector
- Chris CarlsonDirector
- Chris HopkinsDirector
- Shawn LockeryExecutive Officer, Director
- Offering amount
- $1.6M
- Amount sold
- $1.6M
- First sale
- Apr 2018
- Incorporated
- Corporation, Oregon
- Federal exemptions
- 04, 06b, 4a5
▶$2.5MraisedMar 2017 · 23 investors · BiotechnologyRule 506(b)
▶$2.5MraisedMar 2017 · 23 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Matt BeaudetExecutive Officer, Director
- Amy TykesonDirector
- Shawn LockeryExecutive Officer, Director
- Janis WeeksExecutive Officer, Director
- Chris CarlsonDirector
- Offering amount
- $3M
- Amount sold
- $2.5M
- First sale
- Feb 2017
- Incorporated
- Corporation, Oregon
- Federal exemptions
- 06b, 4a5
▶$249.6KofferedApr 2016 · BiotechnologyRule 506(b)
▶$249.6KofferedApr 2016 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Shawn LockeryExecutive Officer, Director
- Amy TykesonDirector
- Chris CarlsonDirector
- Janis WeeksExecutive Officer, Director
- Matt BeaudetExecutive Officer, Director
- Offering amount
- $249.6K
- Incorporated
- Corporation, Oregon, 2011
- Federal exemptions
- 06b
▶$150KraisedSep 2015 · 1 investors · BiotechnologyRule 506(b)
▶$150KraisedSep 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Janis WeeksExecutive Officer, Director
- Matt BeaudetExecutive Officer, Director
- Shawn LockeryExecutive Officer, Director
- Offering amount
- $825K
- Amount sold
- $150K
- First sale
- Sep 2015
- Incorporated
- Corporation, Oregon, 2011
- Federal exemptions
- 06b
▶$20.6KraisedSep 2015 · 1 investors · BiotechnologyRule 506(b)
▶$20.6KraisedSep 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Janis WeeksExecutive Officer, Director
- Matt BeaudetExecutive Officer, Director
- Shawn LockeryExecutive Officer, Director
- Offering amount
- $20.6K
- Amount sold
- $20.6K
- Minimum investment
- $20.6K
- First sale
- Aug 2015
- Incorporated
- Corporation, Oregon, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 10 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $388.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $464.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $474.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $664.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $225K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $224.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2018 | $986.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $350K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $149.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2014 | $158.4K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- Who founded NemaMetrix?
- NemaMetrix was founded by Janis Weeks, Shawn Lockery in 2011.
- Who are NemaMetrix's investors?
- NemaMetrix's investors include Oregon Venture Fund, Rogue Venture Partners.
- How much funding has NemaMetrix raised?
- NemaMetrix has disclosed $9.4M raised across 5 of its 6 known rounds.
- Where is NemaMetrix headquartered?
- NemaMetrix is headquartered in Eugene, US.